What Makes an Antipsychotic ‘Atypical’?Conserving the Definition

被引:0
作者
John L. Waddington
Eadbhard O’Callaghan
机构
[1] Royal College of Surgeons in Ireland,Department of Clinical Pharmacology
[2] Cluain Mhuire Family Centre,undefined
来源
CNS Drugs | 1997年 / 7卷
关键词
Schizophrenia; Clozapine; Sexual Dysfunction; Thioridazine; Amisulpride;
D O I
暂无
中图分类号
学科分类号
摘要
Current usage of the term ‘atypical’ in relation to antipsychotics lacks clear theoretical underpinnings and rigour in application. The prevailing definition of atypicality is a reduced liability to induce extrapyramidal side effects (EPS). However, this definition appears incomplete in the face of numerous other limitations associated with antipsychotics that can impact adversely on patient well-being; these encompass issues of efficacy, non-motoric physiology and quality of life.
引用
收藏
页码:341 / 346
页数:5
相关论文
共 16 条
[1]  
Pickar D(1995)Prospects for pharmacotherapy of schizophrenia Lancet 345 557-62
[2]  
Gerlach J(1994)Drug treatment of schizophrenia: myths and realities Curr Opin Psychiatry 7 65-70
[3]  
Casey DE(1996)Drug therapy: schizophrenia N Engl J Med 334 34-41
[4]  
Kane JM(1996)Adverse effects of antipsychotic agents: do newer agents offer advantages? Drugs 51 895-930
[5]  
Owens DGC(1988)A double blind comparative study of remoxipride and thioridazine in the acute phase of schizophrenia Acta Psychiatr Scand 78 49-56
[6]  
McCreadie RG(1994)The Australian multicentre double-blind comparative study of remoxipride and thioridazine in schizophrenia Acta Psychiatr Scand 90 358-65
[7]  
Todd N(1994)Schizophrenia N Engl J Med 330 681-90
[8]  
Livingston M(1993)Subjective response to neuroleptics in schizophrenia Schizophr Bull 19 609-16
[9]  
Keks N(1989)Schizophrenia, affective psychosis and other disorders treated with neuroleptic drugs: the enigma of tardive dyskinesia, its neurobiological determinants and the conflict of paradigms Int Rev Neurobiol 31 297-353
[10]  
McGrath J(1994)Concensus statement: the use of high dose antipsychotic medication Br J Psychiatry 164 448-58